Home › Funds › Capricorn Fund Managers Ltd › TVTX
Capricorn Fund Managers Ltd position in TVTX
TRAVERE THERAPEUTICS INC · Health Care
Capricorn Fund Managers Ltd reported holding 321,721 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$18.3M, representing 1.46% of its reported portfolio and ranking #19 among its reported holdings. Capricorn Fund Managers Ltd first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Capricorn Fund Managers Ltd's TVTX position evolved
Capricorn Fund Managers Ltd first disclosed a stake in TVTX in Q2 2026 at 321,721 shares (US$18.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 321.72K | $18.28M | New |
About TVTX and 13F data
TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TVTX
- PERCEPTIVE ADVISORS LLC 3.75M sh · $213.18M · Q2 2026
- Rock Springs Capital Management LP 2.18M sh · $123.79M · Q2 2026
- Kynam Capital Management, LP 2.00M sh · $113.62M · Q2 2026
- Stephens Investment Management Group LLC 1.88M sh · $106.54M · Q2 2026
- EMERALD ADVISERS, LLC 1.60M sh · $90.95M · Q2 2026
- MPM BioImpact LLC 1.12M sh · $63.78M · Q2 2026
- Context Capital Management, LLC 50.50M sh · $59.46M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 1.03M sh · $58.63M · Q2 2026
- Eversept Partners, LP 798.97K sh · $45.39M · Q2 2026
- Polar Asset Management Partners Inc. 30.50M sh · $35.91M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 28.00M sh · $32.96M · Q2 2026
- ARMISTICE CAPITAL, LLC 500.00K sh · $28.41M · Q2 2026
More on Capricorn Fund Managers Ltd
FAQ
How long has Capricorn Fund Managers Ltd held TVTX?
Capricorn Fund Managers Ltd has disclosed TVTX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Capricorn Fund Managers Ltd's current position in TVTX?
As of Q2 2026, Capricorn Fund Managers Ltd holds 321.72K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $18.28M, representing 1.46% of its reported portfolio and ranking #19.
Has Capricorn Fund Managers Ltd been buying or selling TVTX?
In the latest 13F filing (Q2 2026), Capricorn Fund Managers Ltd newly opened its position in TVTX.
Which other funds hold TVTX?
Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.